Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1168982.RAgZiOOZlOgztggOeWtECuJV_A6ZvplBqiOykMxftxi9U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1168982.RAgZiOOZlOgztggOeWtECuJV_A6ZvplBqiOykMxftxi9U130_assertion type Assertion NP1168982.RAgZiOOZlOgztggOeWtECuJV_A6ZvplBqiOykMxftxi9U130_head.
- NP1168982.RAgZiOOZlOgztggOeWtECuJV_A6ZvplBqiOykMxftxi9U130_assertion description "[Our findings suggested crosstalk between FTCD and HIF signaling and promoted HCC progression, thus implicating FTCD as a therapeutic target for HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1168982.RAgZiOOZlOgztggOeWtECuJV_A6ZvplBqiOykMxftxi9U130_provenance.
- NP1168982.RAgZiOOZlOgztggOeWtECuJV_A6ZvplBqiOykMxftxi9U130_assertion evidence source_evidence_literature NP1168982.RAgZiOOZlOgztggOeWtECuJV_A6ZvplBqiOykMxftxi9U130_provenance.
- NP1168982.RAgZiOOZlOgztggOeWtECuJV_A6ZvplBqiOykMxftxi9U130_assertion SIO_000772 24686083 NP1168982.RAgZiOOZlOgztggOeWtECuJV_A6ZvplBqiOykMxftxi9U130_provenance.
- NP1168982.RAgZiOOZlOgztggOeWtECuJV_A6ZvplBqiOykMxftxi9U130_assertion wasDerivedFrom befree-2016 NP1168982.RAgZiOOZlOgztggOeWtECuJV_A6ZvplBqiOykMxftxi9U130_provenance.
- NP1168982.RAgZiOOZlOgztggOeWtECuJV_A6ZvplBqiOykMxftxi9U130_assertion wasGeneratedBy ECO_0000203 NP1168982.RAgZiOOZlOgztggOeWtECuJV_A6ZvplBqiOykMxftxi9U130_provenance.